How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

487 results for

Superficial Thrombophlebitis

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

141. Behcet's Syndrome

of the symptoms. There is no cure. Treatment focuses on reducing pain and preventing serious problems. Most people can control symptoms with treatment. NIH: National Institute of Arthritis and Musculoskeletal and Skin Diseases Definition (NCI) A rare chronic inflammatory disorder of unknown etiology. It is characterized by the development of ulcers in the mouth and genital region and uveitis. Other signs and symptoms include arthritis, deep vein thrombosis and superficial thrombophlebitis. Definition (CSP (...) ) rare chronic inflammatory disease involving the small blood vessels; of unknown etiology and characterized by mucocutaneous ulceration in the mouth and genital region and uveitis with hypopyon; the neuroocular form may cause blindness and death; synovitis, thrombophlebitis, gastrointestinal ulcerations, retinal vasculitis, and optic atrophy may occur as well. Definition (MSH) Rare chronic inflammatory disease involving the small blood vessels. It is of unknown etiology and characterized

2018 FP Notebook

142. Deep Vein Thrombosis

) Reduced with below knee graded Encourage 30 minute walk per day ( ) Painful, white leg following ileo-femoral deep vein obstruction Painful, cyanotic, edematous leg following ileo-femoral deep and superficial vein obstruction (capillary obstruction) results if not promptly managed XIII. Precautions Idiopathic DVT associated with undiagnosed malignancy Initiate evaluation for underlying malignancy in the first month of unprovoked DVT Directed history and physical Consider , , , PSA of malignancy (...) , Blodproppsykdommer , Tromboembolisk sykdom Derived from the NIH UMLS ( ) Ontology: Deep Vein Thrombosis (C0149871) Definition (MEDLINEPLUS) Deep vein thrombosis, or DVT, is a that forms in a vein deep in the body. Most deep vein clots occur in the lower leg or thigh. If the vein swells, the condition is called thrombophlebitis. A deep vein thrombosis can break loose and cause a serious problem in the lung, called a . Sitting still for a long time can make you more likely to get a DVT. Some medicines

2018 FP Notebook

143. Baker's cyst

is based on expert opinion in review articles [ ] and [ ]. Differential diagnosis What else might it be? The differential diagnosis of Baker's cyst includes: Deep vein thrombosis (may mimic ruptured Baker's cyst) — for further information, see the CKS topic on . Superficial thrombophlebitis — for further information, see the CKS topic on . Popliteal artery aneurysm. Popliteal varices. Lipoma. Ganglion cyst. Abscess. Haematoma. Synovial haemangioma. Muscular herniation. Benign or malignant tumours (...) [ ] . Complications of Baker's cyst include: Dissection or rupture. The most common complication is rupture, which may be asymptomatic in up to 80% of people [ ]. Dissection can occur when a cyst expands into the adjacent proximal gastrocnemius muscle belly causing pain, warmth, tenderness, and redness of the calf. Rupture may follow, causing a sudden increase in these symptoms. This is known as pseudo-thrombophlebitis syndrome and can be difficult to distinguish clinically from deep vein thrombosis [ ]. Ruptured

2016 NICE Clinical Knowledge Summaries

144. Magnetic Resonance Imaging

selected MRI pulse sequences in order to visualize the blood vessels (arteries). There are three major families of MRA techniques: time of flight (TOF) or inflow angiography, phase contrast (PC) angiography (related to the phase shift of the flowing proton spins) and dynamic gadolinium-enhanced (DGE) MRA. Quantification of flow is also possible using phase contrast acquisitions. Similarly several methods are available to image the deep and superficial venous sinuses with MRI, including contrast

2011 Canadian Association of Radiologists

145. Prevention and management of venous thromboembolism

of thromboprophylaxis 34 9 d iagnosis of venous thromboembolism 36 9.1 Diagnosis of acute venous thromboembolism 36 9.2 Diagnostic algorithms 36 9.3 Confirmation of clinically suspected deep vein thrombosis 38 9.4 Confirmation of clinically suspected pulmonary embolism 38 10 Preliminary assessment 40 10.1 Clinical and laboratory investigations 40 11 initial management of venous thromboembolism 42 11.1 Pulmonary embolism 42 11.2 Lower limb DVT 44 11.3 Superficial thrombophlebitis 45 11.4 Upper extremity DVT 46 11.5 (...) for antithrombotic therapy. a t esting for inherited forms of thrombophilia (antithrombin, protein C, protein S deficiency and factor V Leiden and prothrombin G20210A) does not influence initial management of venous thromboembolism and should not be performed routinely. C u nselective screening for cancer in patients with deep vein thrombosis or pulmonary embolism is not indicated. 2.7 initial management of venous thromboembolism 2.7.1 SUPERFICIAL THROMBOPHLEBITIS d Patients with clinical signs of superficial

2010 SIGN

147. Management of Patients with Infections Caused by Methicillin-Resistant Staphylococcus Aureus Full Text available with Trip Pro

abscess [ ]. Bacteremia accompanies the majority (75%) of cases of invasive MRSA disease [ ]. A multitude of disease manifestations have been described, including, but not limited to, infective endocarditis; myocardial, peri-nephric, hepatic, and splenic abscesses; septic thrombophlebitis with and without pulmonary emboli [ ]; necrotizing pneumonia [ ]; osteomyelitis complicated by subperiosteal abscesses; venous thrombosis and sustained bacteremia [ , , ]; severe ocular infections, including (...) of invasive susceptible CA-MRSA infections in children, including osteomyelitis, septic arthritis, pneumonia, and lymphadenitis [ , ]. Because it is bacteriostatic, it is not recommended for endovascular infections, such as infective endocarditis or septic thrombophlebitis. Clindamycin has excellent tissue penetration, particularly in bone and abscesses, although penetration into the CSF is limited [ ]. In vitro rates of susceptibility to clindamycin are higher among CA-MRSA than they are among HA-MRSA

2011 Infectious Diseases Society of America

148. A multicenter, randomized, placebo-controlled trial of endovenous thermal ablation with or without polidocanol endovenous microfoam treatment in patients with great saphenous vein incompetence and visible varicosities. Full Text available with Trip Pro

trended similarly. Polidocanol endovenous microfoam provided improvements in clinically meaningful change in patient-assessed and physician-assessed appearance ( p < 0.05), need for additional treatment ( p < 0.05), saphenofemoral junction reflux elimination, symptoms, and QOL. In PEM recipients, the most frequent adverse event was superficial thrombophlebitis (35.4%) Conclusions Endovenous thermal ablation + PEM significantly improved physician-assessed appearance at Week 8, increased the proportion (...) A multicenter, randomized, placebo-controlled, blinded study was conducted in patients with great saphenous vein incompetence and symptomatic and visible superficial venous disease. Co-primary endpoints were physician-assessed and patient-assessed appearance change from Baseline to Week 8. Results A total of 117 patients received treatment (38 placebo, 39 PEM 0.5%, 40 PEM 1%). Physician-rated vein appearance at Week 8 was significantly better with PEM ( p = 0.001 vs. placebo); patient-assessed appearance

2016 Phlebology / Venous Forum of the Royal Society of Medicine Controlled trial quality: uncertain

149. Predicting and preventing thromboembolic events in patients receiving cisplatin-based chemotherapy for germ cell tumours. (Abstract)

in patients at risk of deep venous thrombosis (DVT).Between 2001 and 2014, 295 patients received first-line cisplatin-based chemotherapy for GCT. Preventive anticoagulation with low-molecular-weight heparin (LMWH) was progressively implemented in patients with predictive factors. Sixteen patients with evidence of TEE before starting chemotherapy were excluded from the analysis.Among 279 eligible patients, a TEE occurred in 38 (14%) consisting of DVT (n = 26), arterial thrombosis (n = 2), and superficial (...) thrombophlebitis (n = 10). DVT occurred in 26 (12.7%) of 204 patients with risk factors versus two (2.6%) of 75 patients with no risk factors (p = 0.01). After a prevention protocol was progressively implemented from 2005, primary thromboprophylaxis was administered to 104 patients (68%) with risk factors. Among patients at risk (n = 151), the incidence of DVT decreased by roughly half when they received a LMWH: 9/97 (9.2%) and 9/54 (16.6%), respectively (p = 0.23).Patients with GCT who receive cisplatin-based

2016 European Journal of Cancer

150. Abdominal Mondor disease mimicking acute appendicitis Full Text available with Trip Pro

Abdominal Mondor disease mimicking acute appendicitis Mondor disease (MD), a superficial thrombophlebitis of the thoraco-epigastric veins and their confluents is rarely reported in the literature. The superior epigastric vein is the most affected vessel but involvement of the inferior epigastric vessels or their branches have also been described. There is no universal consensus on treatment in the literature but most authors suggest symptomatic treatment with non-steroid anti-inflammatory drugs

2016 International journal of surgery case reports

151. Doppler Ultrasound and Magnetic Resonance Imaging Findings of Penile Mondor’s Disease: Case Report and Literature Review Full Text available with Trip Pro

Doppler Ultrasound and Magnetic Resonance Imaging Findings of Penile Mondor’s Disease: Case Report and Literature Review Penile involvement is a rare, self-limiting, benign genital condition. In Mondor's disease the underlying pathology is thrombophlebitis of a superficial vein.In this case report, we want to present a rare Penile Mondor's disease with literature review.While the diagnosis can be based on history, physical examination and Doppler ultrasound, the necessity of both MRI, MR

2016 Polish Journal of Radiology

152. Behçet's pulmonary artery aneurysms treated with infliximab and monitored with the 6-min walk test Full Text available with Trip Pro

Behçet's pulmonary artery aneurysms treated with infliximab and monitored with the 6-min walk test Pulmonary involvement in Behçet's disease (BD) is uncommon; however, it is potentially fatal due to the risk of massive haemoptysis. We describe the case of a 36-year-old male presenting with a 2-month history of worsening dyspnoea, weight loss, haemoptysis, oral ulceration, erythema nodosum and superficial thrombophlebitis. He was diagnosed with pulmonary vasculitis secondary to BD; however, his

2016 Oxford Medical Case Reports

153. Study to Assess the Efficacy and Safety of Endolex Forte VErsus Diosmin and Hesperidin in Reducing VeNous Insufficiency

research staff using the contacts provided below. For general information, Layout table for eligibility information Ages Eligible for Study: 18 Years to 75 Years (Adult, Older Adult) Sexes Eligible for Study: All Accepts Healthy Volunteers: No Criteria Inclusion Criteria: Patients, male or females aged 18 to 75 years old BMI≤40 Presence of chronic venous insufficiency which is rated between functional classes CEAP 1-4 Patients diagnosed with superficial vein thrombophlebitis and have skin reaction

2016 Clinical Trials

154. Clinical Study of Stent Versus Direct Atherectomy to Treat Arteriosclerosis Occlusive Disease of Lower Extremity

Hospital, Beijing. Recruitment status was: Recruiting First Posted : July 21, 2016 Last Update Posted : July 21, 2016 Sponsor: Xuanwu Hospital, Beijing Collaborators: Beijing Friendship Hospital Beijing Chao Yang Hospital Information provided by (Responsible Party): Xuanwu Hospital, Beijing Study Details Study Description Go to Brief Summary: This is a randomized study comparing stent and plaque excision systems in treatment of Arteriosclerosis occlusive disease of lower extremity (superficial femoral (...) or popliteal artery) Condition or disease Intervention/treatment Phase Atherosclerosis Ischemia Device: plaque excision system Device: Stent Not Applicable Detailed Description: This is a randomized study comparing stent and plaque excision systems in treatment of Arteriosclerosis occlusive disease of lower extremity (superficial femoral or popliteal artery) Study Design Go to Layout table for study information Study Type : Interventional (Clinical Trial) Estimated Enrollment : 120 participants Allocation

2016 Clinical Trials

155. The DESappear Study: Drug Eluting Scaffold

changes; Subject has a groin infection, or an acute systemic infection that has not been treated successfully or is currently under treatment; Subject has acute thrombophlebitis (superficial or deep) in either extremity; Subject has other medical conditions (e.g., cancer, congestive heart failure or substance abuse) that may cause the subject to be non-compliant with protocol requirements or confound data interpretation; Subject is currently participating or wanting to participate in a clinical trial (...) General Hospital Genae Information provided by (Responsible Party): Elixir Medical Corporation Study Details Study Description Go to Brief Summary: The aim of this study is to prospectively collect information to evaluate the safety and performance of the Akesys Prava Sirolimus Eluting Bioresorbable Peripheral scaffold system for the treatment of symptomatic primary atherosclerotic stenoses and occlusions of the superficial femoral artery (SFA). Condition or disease Intervention/treatment Phase

2016 Clinical Trials

156. Catheter-directed Foam Sclerotherapy With Tumescence

Secondary Outcome Measures : Quality of Life Change [ Time Frame: Six months follow-up after the intervention ] It will be measured by the application of the Aberdeen varicose vein questionnaire Complications [ Time Frame: From the intervention until six months follow-up ] It will be considered: anaphylaxis; superficial thrombophlebitis; deep venous thrombosis; pulmonary embolism; visual disturbances; migraine; transient ischemic attack; tissue necrosis; intra arterial injection; neurological injury

2016 Clinical Trials

157. Long Segment Lesion Peripheral Artery Revascularization Feasibility Study

, 2017 See Sponsor: PQ Bypass, Inc. Information provided by (Responsible Party): PQ Bypass, Inc. Study Details Study Description Go to Brief Summary: The primary objective of the feasibility study is to evaluate the safety and effectiveness of the PQ Bypass Stent Graft System in the treatment of atherosclerotic lesions of the native superficial femoral artery (SFA) or the superficial femoral and proximal popliteal arteries. Condition or disease Intervention/treatment Phase Peripheral Arterial Disease (...) Experimental: PQ Bypass Stent Graft System The PQ Bypass™ Stent Graft System is intended for patients with atherosclerotic lesions of the SFA Device: PQ Bypass Stent Graft System The PQ Bypass™ Stent Graft System is indicated to improve luminal diameter in the treatment of patients with symptomatic de novo or restenotic native lesions or occlusions of the superficial femoral artery (SFA) and/or proximal popliteal artery, with reference vessel diameters of 5.0 to 6.7 mm and lesion lengths up to 180 mm

2016 Clinical Trials

158. Clinical Study of Stent Versus Direct Atherectomy to Treat Lower Limb Ischemia

Party): Xuanwu Hospital, Beijing Study Details Study Description Go to Brief Summary: This is a randomized study comparing stent and plaque excision systems in treatment of lower limb (superficial femoral or popliteal artery) ischemia. Condition or disease Intervention/treatment Phase Atherosclerosis Ischemia Device: plaque excision system Device: Stent Not Applicable Detailed Description: This is a randomized study comparing stent and plaque excision systems in treatment of diabetic lower limb (...) (superficial femoral or popliteal artery) ischemia. Study Design Go to Layout table for study information Study Type : Interventional (Clinical Trial) Actual Enrollment : 120 participants Allocation: Randomized Intervention Model: Parallel Assignment Masking: Single (Participant) Primary Purpose: Treatment Study Start Date : January 2014 Actual Primary Completion Date : March 2016 Actual Study Completion Date : April 2016 Arms and Interventions Go to Arm Intervention/treatment Active Comparator

2015 Clinical Trials

159. Evaluation of the Safety of Compressive Socks to Treat Venous Insufficiency in Patients With Peripheral Arterial Disease

from the ankle to the knee. Progressive compressive stockings were developed to have a maximal pressure at the calf. This concept is based on the calf pump role in the venous return. Patients with PAD (Peripheral Arterial Disease) often suffer from venous insufficiency. But elastic compression stockings are strictly contraindicated for patients with PAD because highest pressures on ankle could slow down the superficial microcirculation. On patients with PAD and venous insufficiency, the progressive (...) coerulea dolens Septic thrombophlebitis Severe coronary artery disease Oozing and infectious skin diseases, skin ulcers Known hypersensitivity to components of the study compressive stockings Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02431819

2015 Clinical Trials

160. Parenteral Antibiotics Compared to Combination of Oral and Parenteral Antibiotics in Colorectal Surgery Prophylaxis

] Superficial, deep, body-cavity This is a Clinical measure supported by image if necessary All the morbidity problems are reported independently Secondary Outcome Measures : Hospital stay [ Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 7 days ] Hospital stay since colorectal surgery is done Direct Adverse Drug Reactions [ Time Frame: 24 hours since the drug is taken ] Allergic reactions Intolerance •This morbidity problems are reported independently (...) independently as a YES/NO variable Vascular Complications [ Time Frame: 30 days after surgery ] Deep venous thrombosis, phlebitis, thrombophlebitis, ... This is a Clinical measure supported by more specific test if necessary . This morbidity problems are reported independently as a YES/NO variable Gastrointestinal complications [ Time Frame: 30 days after surgery ] Liver failure, gastrointestinal bleeding, severe malnutrition, ... This is a Clinical measure supported by blood test and further test

2015 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>